Sequential versus triple therapy for the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial
Jyh‐Ming Liou(National Taiwan University), Ming‐Shiang Wu(National Taiwan University), Yao‐Chun Hsu(China Medical University), Chia‐Tung Shun(National Taiwan University), Jiing‐Chyuan Luo(Taipei Veterans General Hospital), Cheng-Hao Tseng(I-Shou University), Chieh‐Chang Chen(National Taiwan University Hospital), Mei‐Jyh Chen(National Taiwan University), Shih–Jer Hsu(National Taiwan University Hospital), Ping‐Huei Tseng(National Taiwan University Hospital), Wen-Hsiung Chang(Mackay Memorial Hospital), Chien-Chuan Chen(National Taiwan University Hospital), Ueng‐Cheng Yang(Taipei Veterans General Hospital), Chi-Yang Chang(I-Shou University), Ji–Yuh Lee(National Taiwan University Hospital), Yu-Jen Fang(National Taiwan University Hospital), Yi‐Chia Lee(National Taiwan University), Hsiu-Po Wang(National Taiwan University Hospital), Jaw‐Town Lin(National Health Research Institutes)
Cited by 268
Related Papers
Association Between Helicobacter pylori Eradication and Gastric Cancer Incidence: A Systematic Review and Meta-analysis
|Gastroenterology|2016|1k
Screening for gastric cancer in Asia: current evidence and practice
|The Lancet Oncology|2008|830
Altered gut microbiota and inflammatory cytokine responses in patients with Parkinson’s disease
|Journal of Neuroinflammation|2019|468
Global Prevalence of Helicobacter pylori Infection and Incidence of Gastric Cancer Between 1980 and 2022
|Gastroenterology|2024|449